Results 1 to 10 of about 32,381 (163)
Development of the general chapters of the Chinese Pharmacopoeia 2020 edition: A review
Journal of Pharmaceutical Analysis, 2021 The Chinese Pharmacopoeia 2020 edition was reviewed and approved by the National Medical Products Administration and the National Health Commission of the People's Republic of China in July 2020. The current edition was officially implemented on December
Zhaopeng Yang
exaly +3 more sources
Journal of Pharmaceutical Analysis, 2021 As an important branch of medicine, Traditional Chinese Medicine (TCM) has been applied for the treatment of diseases for thousands of years in China and other countries in East Asia.
Ming-Rui Shen, Yi He, Shang-Mei Shi
exaly +3 more sources
Pharmacopoeia roles and responses: A systemic resilience approach to COVID-19 pandemic
Saudi Pharmaceutical Journal, 2022 The Coronavirus Disease (COVID-19) is sweeping around the world at a rapid pace resulting in severe health crises across the globe. The pandemic condition has forced the government, regulatory authorities, bio/pharmaceutical industry, and healthcare ...
Shruti Rastogi +6 more
doaj +1 more source
Saudi Pharmaceutical Journal, 2023 India has a sparkling pharmaceutical sector that holds a distinguished place by producing and supplying high-quality and affordable medicines across the globe.
Gaurav Pratap Singh Jadaun +8 more
doaj +1 more source
Monitoring of residual solvent contamination in herbal medicinal products in Ghana: A pilot study
Scientific African, 2021 The use of herbal medicinal products for complementary and alternative medicine is well established in Ghana. The potential public health risks associated with the use of these products due to the presence of residual solvents have not yet been ...
Kwabena F.M. Opuni +5 more
doaj +1 more source
Public-private partnership (3Ps) in ensuring safe use of medicines: An Indian experience
Frontiers in Public Health, 2022 Adverse drug reactions (ADRs) are major concerns to the public health. To monitor ADRs and ensure patients' safety, the Pharmacovigilance Programme of India (PvPI) has been established by the Government of India in 2010.
Vivekanandan Kalaiselvan +4 more
doaj +1 more source
International Journal of Microbiology, 2022 Antibiotic resistance represents one of the biggest challenges, and there is an urgent need for plant-based antimicrobial agents that enable managing this crisis effectively.
Kandasamy Nagarajan +9 more
doaj +1 more source
NMR as Used in the Russian and Foreign Pharmacopoeias for Quality Control of Medicinal Products
Регуляторные исследования и экспертиза лекарственных средств, 2022 The ongoing development of the Pharmacopoeia of the Eurasian Economic Union and the current trend for harmonisation of the Russian Pharmacopoeia with the world leading pharmacopoeias suggest the necessity of studying how different pharmacopoeias use ...
S. V. Moiseev +2 more
doaj +1 more source
Regulation of Radiopharmaceutical Products
Регуляторные исследования и экспертиза лекарственных средств, 2022 The fast development of diagnostic and therapeutic radionuclide technologies requires enhanced legislative regulation of radiopharmaceuticals. The article addresses the challenge of classifying radiopharmaceuticals depending on the manufacturing ...
V. V. Kosenko +2 more
doaj +1 more source
Modern methods for identification and quantification of cardiac glycosides
Регуляторные исследования и экспертиза лекарственных средств, 2023 Scientific relevance. Cardiac glycosides have been used in medicine for over two centuries. Current studies suggest that biologically active substances from this group can be used to treat not only heart conditions but also viral infections, cancers, and
O. V. Evdokimova +6 more
doaj +1 more source